Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study - Whether the Administration of the Dronabinol and PEA May Act as a Therapy for Obstructive Sleep Apnea

NCT03646552 is registered in ClinicalTrials.gov with Neurothera Labs Inc. as lead sponsor.

NCT NCT03646552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03646552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study - Whether the Administration of the Dronabinol and PEA May Act as a Therapy for Obstructive Sleep Apnea
Lead sponsor
Neurothera Labs Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
June 4, 2018
Completion date
April 30, 2019
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea